Streetbeat News

NYXH

Nyxoah S.A.

https://www.nyxoah.com

Industry

Medical - Instruments & Supplies

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Open

10.44

Mkt cap

365M

Volume

71K

High

10.63

P/E Ratio

-5.38

52-wk high

16.08

Low

10.35

Div yield

N/A

52-wk low

6.76

Nyxoah (NASDAQ:NYXH) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.40. The company's past performance shows a mixed reaction to earnings reports, with the last quarter beating estimates but followed by a 15.1% drop in share price. Shares have risen 187.02% over the last 52 weeks, indicating long-term shareholder optimism.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:02 pm

HC Wainwright & Co. analyst Edward White has maintained a Buy rating on Nyxoah (NASDAQ:NYXH) and increased the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 6:37 pm

TransMedics Group, Inc. (TMDX) shares surged 23.5% in pre-market trading after reporting Q4 earnings of 12 cents per share, surpassing estimates for a 3 cent loss, and sales of $81.17 million, beating expectations of $68.51 million. The company also issued strong guidance. Other stocks showed significant movement in pre-market trading, with notable gainers including Janux Therapeutics, Inc. (JANX), PubMatic, Inc. (PUBM), and losers like The Aaron's Company, Inc. (AAN), and Unity Software Inc. (U).

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 12:56 pm

Unity Software Inc. reported mixed Q4 results, with a revenue increase of 35% to $609 million but a larger-than-expected loss of 66 cents per share. The company's shares fell 17.7% in pre-market trading. Other stocks also moved lower in pre-market trading, including The Aaron's Company, Intuitive Machines, CarGurus, Nyxoah S.A., Five9, Workday, Gaotu Techedu, and Hess Corporation, due to various reasons such as missed estimates, mission failures, and financial results announcements.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 10:06 am

Surgery Partners reported weak quarterly sales, causing its shares to fall 7.8%. Other stocks like Intuitive Machines, Nyxoah, Jin Medical International, and several others also recorded losses. Notably, Intuitive Machines dropped 25.1% due to a lunar lander incident, and Kosmos Energy saw a 7% decline despite beating revenue expectations.

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 4:19 pm

Cantor Fitzgerald analyst Ross Osborn has maintained an Overweight rating on Nyxoah (NASDAQ:NYXH) and increased the price target from $10 to $14.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 2:27 pm

PayPal Holdings, Inc. (NASDAQ:PYPL) shares fell 8.3% in pre-market trading after reporting Q4 results with earnings in line with last year's, contrary to analyst expectations for higher earnings. Other stocks like Digital Turbine, Inc. (NASDAQ:APPS), Axcelis Technologies, Inc. (NASDAQ:ACLS), Rapid7, Inc. (NASDAQ:RPD), GoPro, Inc. (NASDAQ:GPRO), Nyxoah S.A. (NASDAQ:NYXH), ZIM Integrated Shipping Services Ltd. (NYSE:ZIM), and Sana Biotechnology, Inc. (NASDAQ:SANA) also recorded losses in pre-market trading due to various reasons including financial results and public offering pricing.

Portfolio Pulse from Avi Kapoor

February 08, 2024 | 9:49 am

Snap Inc. reported mixed Q4 results with a revenue miss and a weak Q1 revenue forecast, leading to a 31.3% drop in pre-market trading. Other stocks like fuboTV, Diversified Energy, New York Community Bancorp, Cognizant, KKR Real Estate Finance Trust, Nyxoah, V.F. Corporation, ePlus, Weibo, and Pinterest also saw pre-market declines due to various factors including earnings reports and credit downgrades.

Portfolio Pulse from Avi Kapoor

February 07, 2024 | 10:13 am

FMC Corporation's shares fell by around 10% after reporting Q4 results below market expectations. Other stocks showed significant movement, with InVivo Therapeutics and Tenax Therapeutics among the top gainers, while Sunworks and BioRestorative Therapies led the losers. Notable movements were also seen in Palantir Technologies, GE HealthCare Technologies, and Toyota Motor Corporation following their earnings reports.

Portfolio Pulse from Avi Kapoor

February 06, 2024 | 6:17 pm

Palantir Technologies Inc. shares surged 18% in pre-market trading after reporting Q4 sales above expectations and providing guidance. Other stocks also showed significant pre-market movements, with InVivo Therapeutics, Chenghe Acquisition, and Exicure among the top gainers, while Peraso Inc., Trio Petroleum, and Symbotic Inc. led the losers.

Portfolio Pulse from Avi Kapoor

February 06, 2024 | 1:16 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.